FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ARNTL-RIC8B

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ARNTL-RIC8B
FusionPDB ID: 6752
FusionGDB2.0 ID: 6752
HgeneTgene
Gene symbol

ARNTL

RIC8B

Gene ID

406

55188

Gene namearyl hydrocarbon receptor nuclear translocator likeRIC8 guanine nucleotide exchange factor B
SynonymsBMAL1|BMAL1c|JAP3|MOP3|PASD3|TIC|bHLHe5RIC8|hSyn
Cytomap

11p15.3

12q23.3

Type of geneprotein-codingprotein-coding
Descriptionaryl hydrocarbon receptor nuclear translocator-like protein 1ARNT-like protein 1, brain and musclePAS domain containing 3PAS domain-containing protein 3bHLH-PAS protein JAP3basic helix-loop-helix family member e5basic-helix-loop-helix-PAS orphan MOPsynembryn-Bbrain synembrinbrain synembrynresistance to inhibitors of cholinesterase 8 homolog B
Modification date2020032220200313
UniProtAcc

Q8WYA1

Main function of 5'-partner protein: FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. The CLOCK-ARNTL2/BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. {ECO:0000269|PubMed:11018023, ECO:0000269|PubMed:12738229, ECO:0000269|PubMed:14672706}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000497429, ENST00000361003, 
ENST00000389707, ENST00000389708, 
ENST00000396441, ENST00000401424, 
ENST00000403290, ENST00000403482, 
ENST00000403510, 
ENST00000355478, 
ENST00000392837, ENST00000392839, 
ENST00000549643, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 8 X 7=3925 X 5 X 4=100
# samples 106
** MAII scorelog2(10/392*10)=-1.97085365434048
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/100*10)=-0.736965594166206
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ARNTL [Title/Abstract] AND RIC8B [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ARNTL [Title/Abstract] AND RIC8B [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ARNTL(13381971)-RIC8B(107219504), # samples:3
Anticipated loss of major functional domain due to fusion event.ARNTL-RIC8B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ARNTL-RIC8B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ARNTL-RIC8B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ARNTL-RIC8B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneARNTL

GO:0032922

circadian regulation of gene expression

24005054

HgeneARNTL

GO:0045893

positive regulation of transcription, DNA-templated

11441146|12738229|23785138

HgeneARNTL

GO:0045944

positive regulation of transcription by RNA polymerase II

20093779

HgeneARNTL

GO:0051775

response to redox state

11441146

TgeneRIC8B

GO:0008277

regulation of G protein-coupled receptor signaling pathway

12652642



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:13381971/chr12:107219504)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ARNTL (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RIC8B (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000396441ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50518123531753466
ENST00000396441ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24058123531633426
ENST00000396441ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31108123531681442
ENST00000389707ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50868473881788466
ENST00000389707ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24408473881668426
ENST00000389707ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31458473881716442
ENST00000401424ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50958564151797460
ENST00000401424ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24498564151677420
ENST00000401424ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31548564151725436
ENST00000389708ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50538143551755466
ENST00000389708ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24078143551635426
ENST00000389708ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31128143551683442
ENST00000361003ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50538143551755466
ENST00000361003ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24078143551635426
ENST00000361003ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31128143551683442
ENST00000403290ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50538143551755466
ENST00000403290ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24078143551635426
ENST00000403290ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31128143551683442
ENST00000403510ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+50588194591760433
ENST00000403510ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+24128194591640393
ENST00000403510ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+31178194591688409
ENST00000403482ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219504+469645741398464
ENST00000403482ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219504+205045741278424
ENST00000403482ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219504+275545741326440
ENST00000396441ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50518123531753466
ENST00000396441ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24058123531633426
ENST00000396441ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31108123531681442
ENST00000389707ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50868473881788466
ENST00000389707ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24408473881668426
ENST00000389707ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31458473881716442
ENST00000401424ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50958564151797460
ENST00000401424ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24498564151677420
ENST00000401424ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31548564151725436
ENST00000389708ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50538143551755466
ENST00000389708ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24078143551635426
ENST00000389708ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31128143551683442
ENST00000361003ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50538143551755466
ENST00000361003ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24078143551635426
ENST00000361003ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31128143551683442
ENST00000403290ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50538143551755466
ENST00000403290ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24078143551635426
ENST00000403290ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31128143551683442
ENST00000403510ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+50588194591760433
ENST00000403510ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+24128194591640393
ENST00000403510ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+31178194591688409
ENST00000403482ARNTLchr1113381971+ENST00000392837RIC8Bchr12107219503+469645741398464
ENST00000403482ARNTLchr1113381971+ENST00000392839RIC8Bchr12107219503+205045741278424
ENST00000403482ARNTLchr1113381971+ENST00000355478RIC8Bchr12107219503+275545741326440

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000396441ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0003923980.9996076
ENST00000396441ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0013898260.99861014
ENST00000396441ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005719880.999428
ENST00000389707ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0003824580.99961746
ENST00000389707ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0012528280.9987471
ENST00000389707ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005457060.9994543
ENST00000401424ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0005196980.9994803
ENST00000401424ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.001834590.9981654
ENST00000401424ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0007611030.99923897
ENST00000389708ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0003833260.9996166
ENST00000389708ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0012285670.99877137
ENST00000389708ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005402280.9994598
ENST00000361003ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0003833260.9996166
ENST00000361003ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0012285670.99877137
ENST00000361003ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005402280.9994598
ENST00000403290ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0003833260.9996166
ENST00000403290ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0012285670.99877137
ENST00000403290ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005402280.9994598
ENST00000403510ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0005182990.99948174
ENST00000403510ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0016980920.99830186
ENST00000403510ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0007358870.99926406
ENST00000403482ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219504+0.0004079670.999592
ENST00000403482ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219504+0.0011979290.99880207
ENST00000403482ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219504+0.0005192190.9994808
ENST00000396441ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0003923980.9996076
ENST00000396441ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0013898260.99861014
ENST00000396441ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005719880.999428
ENST00000389707ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0003824580.99961746
ENST00000389707ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0012528280.9987471
ENST00000389707ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005457060.9994543
ENST00000401424ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0005196980.9994803
ENST00000401424ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.001834590.9981654
ENST00000401424ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0007611030.99923897
ENST00000389708ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0003833260.9996166
ENST00000389708ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0012285670.99877137
ENST00000389708ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005402280.9994598
ENST00000361003ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0003833260.9996166
ENST00000361003ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0012285670.99877137
ENST00000361003ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005402280.9994598
ENST00000403290ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0003833260.9996166
ENST00000403290ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0012285670.99877137
ENST00000403290ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005402280.9994598
ENST00000403510ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0005182990.99948174
ENST00000403510ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0016980920.99830186
ENST00000403510ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0007358870.99926406
ENST00000403482ENST00000392837ARNTLchr1113381971+RIC8Bchr12107219503+0.0004079670.999592
ENST00000403482ENST00000392839ARNTLchr1113381971+RIC8Bchr12107219503+0.0011979290.99880207
ENST00000403482ENST00000355478ARNTLchr1113381971+RIC8Bchr12107219503+0.0005192190.9994808

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ARNTL-RIC8B

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ARNTLchr1113381971RIC8Bchr12107219503457151FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219503812153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219503814153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219503819120FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219503847153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219503856147FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504457151FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504812153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504814153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504819120FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504847153FLSDDELKHLILRSDSHQFRVMAAVL
ARNTLchr1113381971RIC8Bchr12107219504856147FLSDDELKHLILRSDSHQFRVMAAVL

Top

Potential FusionNeoAntigen Information of ARNTL-RIC8B in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ARNTL-RIC8B_13381971_107219503.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:18LRSDSHQF0.97640.62371119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:01ILRSDSHQF0.99940.5491019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:25ILRSDSHQF0.9920.80631019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:02ILRSDSHQF0.98990.82331019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A32:13ILRSDSHQF0.66370.80481019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B13:02RSDSHQFRV0.58910.73131221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B13:01ILRSDSHQF0.03150.69021019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:01LILRSDSHQF0.99670.5393919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:25LILRSDSHQF0.98590.8162919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A74:11ILRSDSHQFR0.94790.69791020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A74:09ILRSDSHQFR0.94790.69791020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A74:03ILRSDSHQFR0.94790.69791020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A31:02ILRSDSHQFR0.9470.66011020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A31:06ILRSDSHQFR0.86710.60171020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:01HLILRSDSHQF0.99940.5465819
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:95LRSDSHQF0.99940.5641119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:27LRSDSHQF0.99910.91221119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:67LRSDSHQF0.99830.86821119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:80LRSDSHQF0.99830.86821119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:46LRSDSHQF0.9980.75041119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C12:16LRSDSHQF0.95610.93541119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C05:09RSDSHQFRV10.92571221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C04:07RSDSHQFRV0.99990.90891221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:15RSDSHQFRV0.99970.95641221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C15:06RSDSHQFRV0.99880.87021221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C04:06RSDSHQFRV0.99830.89241221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:21ILRSDSHQF0.98820.72451019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:04ILRSDSHQF0.98650.55411019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C04:14RSDSHQFRV0.94630.91021221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:04RSDSHQFRV0.88020.9471221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:13RSDSHQFRV0.88020.9471221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:05ILRSDSHQF0.81340.65351019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:31ILRSDSHQF0.78270.66051019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:03RSDSHQFRV0.56010.96821221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C03:14ILRSDSHQF0.48390.9071019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C02:06RSDSHQFRV0.4770.95251221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:15RSDSHQFRVM0.99990.92751222
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C05:09RSDSHQFRVM0.99990.89081222
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A31:01ILRSDSHQFR0.96330.6441020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A02:07ILRSDSHQFRV0.81250.53621021
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:22LRSDSHQF0.99920.54321119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:02LRSDSHQF0.99830.86821119
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C05:01RSDSHQFRV10.92571221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C04:03RSDSHQFRV10.91311221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C18:01RSDSHQFRV0.99990.90991221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C04:01RSDSHQFRV0.99990.90891221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:02RSDSHQFRV0.99970.95641221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:135ILRSDSHQF0.99950.59791019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:34ILRSDSHQF0.99940.5491019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:125ILRSDSHQF0.99940.5491019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:35ILRSDSHQF0.99940.54171019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:33ILRSDSHQF0.99940.5491019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:27ILRSDSHQF0.99940.60491019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C15:02RSDSHQFRV0.99930.75261221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:50ILRSDSHQF0.99930.70091019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:24ILRSDSHQF0.99910.65161019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:08ILRSDSHQF0.99910.50291019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C15:05RSDSHQFRV0.99910.78621221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:53ILRSDSHQF0.99870.50621019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:12ILRSDSHQF0.99580.63661019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C16:02RSDSHQFRV0.97570.98141221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:13ILRSDSHQF0.96750.60051019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C12:02ILRSDSHQF0.96730.92291019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C03:02ILRSDSHQF0.9430.86691019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:73ILRSDSHQF0.92770.58121019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A32:01ILRSDSHQF0.85790.79891019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:20ILRSDSHQF0.80390.79771019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B35:28ILRSDSHQF0.75720.80881019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B35:20ILRSDSHQF0.73710.81821019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C17:01RSDSHQFRV0.64920.94041221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:01RSDSHQFRV0.56010.96821221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C02:10ILRSDSHQF0.420.89381019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C02:02ILRSDSHQF0.420.89381019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B48:02ILRSDSHQF0.39660.78361019
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C07:04RSDSHQFRV0.35710.94591221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B07:13RSDSHQFRV0.00560.7761221
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C05:01RSDSHQFRVM0.99990.89081222
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-C08:02RSDSHQFRVM0.99990.92751222
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:27LILRSDSHQF0.99680.6317919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:34LILRSDSHQF0.99670.5393919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:33LILRSDSHQF0.99670.5393919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:125LILRSDSHQF0.99670.5393919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:135LILRSDSHQF0.99640.5686919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:35LILRSDSHQF0.99590.5355919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:50LILRSDSHQF0.99290.5767919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:12LILRSDSHQF0.98710.5807919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:39LILRSDSHQF0.98570.5008919
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-A74:01ILRSDSHQFR0.94790.69791020
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:33HLILRSDSHQF0.99940.5465819
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:34HLILRSDSHQF0.99940.5465819
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:125HLILRSDSHQF0.99940.5465819
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:12HLILRSDSHQF0.99230.6046819
ARNTL-RIC8Bchr1113381971chr12107219503814HLA-B15:20HLILRSDSHQF0.96830.661819

Top

Potential FusionNeoAntigen Information of ARNTL-RIC8B in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ARNTL-RIC8B_13381971_107219503.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0301HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0301KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0301LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0303HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0303KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0303LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0307HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0307KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0313HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0313KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0313LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0318HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0318KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0318LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0320HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0320KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0320LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0322HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0322KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0322LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0326HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0326KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0328HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0328KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0328LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0330HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0330KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0330LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0332HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0332KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0332LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0334HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0334KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0334LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0336HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0336KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0336LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0344HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0344KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0344LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0346HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0346KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0346LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0348HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0348KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0348LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0350HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0350KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0350LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0352HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0352KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0352LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0354HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0354KHLILRSDSHQFRVM722
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-0354LKHLILRSDSHQFRV621
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-1107HLILRSDSHQFRVMA823
ARNTL-RIC8Bchr1113381971chr12107219503814DRB1-1107KHLILRSDSHQFRVM722

Top

Fusion breakpoint peptide structures of ARNTL-RIC8B

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5157LKHLILRSDSHQFRARNTLRIC8Bchr1113381971chr12107219503814

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ARNTL-RIC8B

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5157LKHLILRSDSHQFR-7.9962-8.1096
HLA-B14:023BVN5157LKHLILRSDSHQFR-5.70842-6.74372
HLA-B52:013W395157LKHLILRSDSHQFR-6.83737-6.95077
HLA-B52:013W395157LKHLILRSDSHQFR-4.4836-5.5189
HLA-A11:014UQ25157LKHLILRSDSHQFR-10.0067-10.1201
HLA-A11:014UQ25157LKHLILRSDSHQFR-9.03915-10.0745
HLA-A24:025HGA5157LKHLILRSDSHQFR-6.56204-6.67544
HLA-A24:025HGA5157LKHLILRSDSHQFR-5.42271-6.45801
HLA-B44:053DX85157LKHLILRSDSHQFR-7.85648-8.89178
HLA-B44:053DX85157LKHLILRSDSHQFR-5.3978-5.5112
HLA-A02:016TDR5157LKHLILRSDSHQFR-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of ARNTL-RIC8B

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ARNTL-RIC8Bchr1113381971chr121072195031019ILRSDSHQFATTCTCAGGAGTGATTCTCATCAGTTC
ARNTL-RIC8Bchr1113381971chr121072195031020ILRSDSHQFRATTCTCAGGAGTGATTCTCATCAGTTCCGT
ARNTL-RIC8Bchr1113381971chr121072195031021ILRSDSHQFRVATTCTCAGGAGTGATTCTCATCAGTTCCGTGTA
ARNTL-RIC8Bchr1113381971chr121072195031119LRSDSHQFCTCAGGAGTGATTCTCATCAGTTC
ARNTL-RIC8Bchr1113381971chr121072195031221RSDSHQFRVAGGAGTGATTCTCATCAGTTCCGTGTA
ARNTL-RIC8Bchr1113381971chr121072195031222RSDSHQFRVMAGGAGTGATTCTCATCAGTTCCGTGTAATG
ARNTL-RIC8Bchr1113381971chr12107219503819HLILRSDSHQFCACCTCATTCTCAGGAGTGATTCTCATCAGTTC
ARNTL-RIC8Bchr1113381971chr12107219503919LILRSDSHQFCTCATTCTCAGGAGTGATTCTCATCAGTTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ARNTL-RIC8Bchr1113381971chr12107219503621LKHLILRSDSHQFRVTTGAAACACCTCATTCTCAGGAGTGATTCTCATCAGTTCCGTGTA
ARNTL-RIC8Bchr1113381971chr12107219503722KHLILRSDSHQFRVMAAACACCTCATTCTCAGGAGTGATTCTCATCAGTTCCGTGTAATG
ARNTL-RIC8Bchr1113381971chr12107219503823HLILRSDSHQFRVMACACCTCATTCTCAGGAGTGATTCTCATCAGTTCCGTGTAATGGCA

Top

Information of the samples that have these potential fusion neoantigens of ARNTL-RIC8B

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCARNTL-RIC8Bchr1113381971ENST00000361003chr12107219503ENST00000355478TCGA-DX-A3LT

Top

Potential target of CAR-T therapy development for ARNTL-RIC8B

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ARNTL-RIC8B

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ARNTL-RIC8B

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource